Miltefosine (Hexadecylphosphocholine) Inhibits Cytochrome c Oxidase in Leishmania donovani Promastigotes

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2007-02-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.01415-06PMID 17283192PMCID PMC1855476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in Leishmania donovani Clinical Field Isolates by Modulating Drug-induced Programmed Cell Death*

  2007cited by this paper
• Drug Resistance in Leishmaniasis

  2006cited by this paper
• Phospholipid Translocation and Miltefosine Potency Require Both L. donovani Miltefosine Transporter and the New Protein LdRos3 in Leishmania Parasites*

  2006cited by this paper
• Chemotherapy in the treatment and control of leishmaniasis.

  2006cited by this paper
• Ultrastructural analysis of edelfosine-treated trypomastigotes and amastigotes of Trypanosoma cruzi

  2006cited by this paper
• Proteomic screen implicates HSP 83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death

  2006cited by this paper
• Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.

  2006cited by this paper
• Photolabeling of cardiolipin binding subunits within bovine heart cytochrome c oxidase.

  2006cited by this paper
• Lower Nitric Oxide Susceptibility of Trivalent Antimony-Resistant Amastigotes of Leishmania infantum

  2005cited by this paper
• Alteration of Fatty Acid and Sterol Metabolism in Miltefosine-Resistant Leishmania donovani Promastigotes and Consequences for Drug-Membrane Interactions

  2005cited by this paper
• Energy metabolism and its compartmentation in Trypanosoma brucei.

  2005cited by this paper
• A role for the protein in internal electron transfer to the catalytic center of cytochrome c oxidase.

  2005cited by this paper
• Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis.

  2005cited by this paper
• Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.

  2005cited by this paper
• Sudanese mucosal leishmaniasis: isolation of a parasite within the Leishmania donovani complex that differs genotypically from L. donovani causing classical visceral leishmaniasis.

  2005cited by this paper
• Antiprotozoal lysophospholipid analogues: a comparison of their activity against trypanosomatid parasites and tumor cells.

  2004cited by this paper
• The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases.

  2004cited by this paper
• Possible Mechanism of Miltefosine-Mediated Death of Leishmania donovani

  2004cited by this paper
• Miltefosine Induces Apoptosis-Like Death in Leishmania donovani Promastigotes

  2004influential reference
• Miltefosine (Impavido): the first oral treatment against leishmaniasis

  2004cited by this paper
• Fungus-Elicited Metabolites from Plants as an Enriched Source for New Leishmanicidal Agents: Antifungal Phenyl-Phenalenone Phytoalexins from the Banana Plant (Musa acuminata) Target Mitochondria of Leishmania donovani Promastigotes

  2004cited by this paper
• Leishmaniasis: drugs in the clinic, resistance and new developments.

  2004cited by this paper
• Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.

  2004influential reference
• Miltefosine for new world cutaneous leishmaniasis.

  2004cited by this paper
• Cardiolipin Biosynthesis and Mitochondrial Respiratory Chain Function Are Interdependent*

  2004cited by this paper
• Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers.

  2003cited by this paper
• Programmed cell death in trypanosomatids and other unicellular organisms.

  2003cited by this paper
• Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP.

  2003cited by this paper
• Functional Cloning of the Miltefosine Transporter

  2003influential reference
• Antiprotozoal activities of phospholipid analogues.

  2003cited by this paper
• Leishmania donovani Resistance to Miltefosine Involves a Defective Inward Translocation of the Drug

  2003cited by this paper
• Leishmania/HIV co-infections: epidemiology in Europe

  2003cited by this paper
• Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).

  2003influential reference
• Aurones Interfere with Leishmania major Mitochondrial Fumarate Reductase

  2002cited by this paper
• Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells.

  2002cited by this paper
• Increase in Cytosolic Ca2+ Levels through the Activation of Non-selective Cation Channels Induced by Oxidative Stress Causes Mitochondrial Depolarization Leading to Apoptosis-like Death in Leishmania donovaniPromastigotes*

  2002cited by this paper
• Increase in Cytosolic Ca 2 (cid:1) Levels through the Activation of Non-selective Cation Channels Induced by Oxidative Stress Causes Mitochondrial Depolarization Leading to Apoptosis-like Death in Leishmania donovani Promastigotes*

  2002cited by this paper
• Detergent modulation of electron and proton transfer reactions in bovine cytochrome c oxidase.

  2002cited by this paper
• Inhibition of Fumarate Reductase inLeishmania major and L. donovani by Chalcones

  2001cited by this paper
• In Vivo Monitoring of Intracellular ATP Levels inLeishmania donovani Promastigotes as a Rapid Method To Screen Drugs Targeting Bioenergetic Metabolism

  2001cited by this paper
• N-Terminal Fatty Acid Substitution Increases the Leishmanicidal Activity of CA(1-7)M(2-9), a Cecropin-Melittin Hybrid Peptide

  2001cited by this paper
• Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole.

  2001cited by this paper
• The origin and evolution of the Leishmania donovani complex as inferred from a mitochondrial cytochrome oxidase II gene sequence.

  2001cited by this paper
• Antimonial-Mediated DNA Fragmentation inLeishmania infantum Amastigotes

  2001cited by this paper
• Ether--lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether--lipid analogues in Leishmania.

  2000cited by this paper
• Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid‐induced apoptosis

  2000cited by this paper
• Expression and regulation of mitochondrial uncoupling protein 1 from brown adipose tissue in Leishmania major promastigotes.

  1998cited by this paper
• The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide.

  1998cited by this paper
• Inhibition of the respiratory chain results in a reversible metabolic arrest in Leishmania promastigotes.

  1997cited by this paper
• The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria

  1995cited by this paper
• Digitonin permeabilization does not affect mitochondrial function and allows the determination of the mitochondrial membrane potential of Trypanosoma cruzi in situ.

  1991cited by this paper
• A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites.

  1990cited by this paper
• Protonmotive force-driven active transport of D-glucose and L-proline in the protozoan parasite Leishmania donovani.

  1985cited by this paper
• AN ELECTRON-TRANSPORT SYSTEM ASSOCIATED WITH THE OUTER MEMBRANE OF LIVER MITOCHONDRIA

  1967influential reference

• Anti-Parasitics with a Triple Threat: Targeting Parasite Enzymes, the Proton Motive Force, and Host Cell-Mediated Killing

  2025cites this paper
• Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy

  2025cites this paper
• Targeting Trypanothione Synthetase and Trypanothione Reductase: Development of Common Inhibitors to Tackle Trypanosomatid Disease

  2025cites this paper
• Current state of the art of gold complexes as antileishmanial agents

  2025cites this paper
• Compounds with potentialities as novel chemotherapeutic agents in leishmaniasis at preclinical level.

  2024cites this paper
• Characterization of differentially regulated carboxypeptidase (metallopeptidase M32) protein in Miltefosine resistant Leishmania donovani parasites.

  2024cites this paper
• Combination Therapy for Post-Kala-Azar Dermal Leishmaniasis: A Literature Review of Current Evidence

  2024cites this paper
• Epoxy-a-lapachone in nanosystem: a prototype drug for leishmaniasis assessed in the binomial BALB/c - Leishmania (Leishmania) amazonensis

  2024cites this paper
• Miltefosine Induces Reproductive Toxicity During Sperm Capacitation by Altering PI3K/AKT Signaling Pathway.

  2024cites this paper
• Synergistic Effects of Artesunate in Combination with Amphotericin B and Miltefosine against Leishmania infantum: Potential for Dose Reduction and Enhanced Therapeutic Strategies

  2024cites this paper
• Miltefosine impacts small molecule transport in Gram-positive bacteria

  2024cites this paper
• High-throughput prioritization of target proteins for development of new antileishmanial compounds

  2024cites this paper
• Unmasking the Mechanism behind Miltefosine: Revealing the Disruption of Intracellular Ca2+ Homeostasis as a Rational Therapeutic Target in Leishmaniasis and Chagas Disease

  2024cites this paper
• The binuclear cyclopalladated complex CP2 is targeting ubiquinol-cytochrome c reductase (complex III) of Leishmania amazonensis

  2024cites this paper
• In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against Leishmania

  2024cites this paper
• The Antileishmanial Activity of Eugenol Associated with Lipid Storage Reduction Rather Than Membrane Properties Alterations

  2023cites this paper
• Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host

  2023cites this paper
• Monitoring Cutaneous Leishmaniasis Lesions in Mice Undergoing Topical Miltefosine Treatment

  2023cites this paper
• Quinolinyl β-enaminone derivatives exhibit leishmanicidal activity against Leishmania donovani by impairing the mitochondrial electron transport chain complex and inducing ROS-mediated programmed cell death.

  2022cites this paper
• A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model

  2022cites this paper
• Energy metabolism as a target for cyclobenzaprine: A drug candidate against Visceral Leishmaniasis.

  2022cites this paper
• Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis

  2022cites this paper
• Different Drugs, Same End: Ultrastructural Hallmarks of Autophagy in Pathogenic Protozoa

  2022cites this paper
• Transcriptome Analysis of Intracellular Amastigotes of Clinical Leishmania infantum Lines from Therapeutic Failure Patients after Infection of Human Macrophages

  2022cites this paper
• FRB domain of human TOR protein induces compromised proliferation and mitochondrial dysfunction in Labrus donovani promastigotes.

  2022cites this paper
• Unraveling of interacting protein network of chaperonin TCP1 gamma subunit of Leishmania donovani

  2022cites this paper
• In-Depth Quantitative Proteomics Characterization of In Vitro Selected Miltefosine Resistance in Leishmania infantum

  2022cites this paper
• Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine

  2021cites this paper
• In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route.

  2021cites this paper
• The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade

  2021cites this paper
• Lipid and fatty acid metabolism in trypanosomatids

  2021cites this paper
• Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition

  2021cites this paper
• The ultimate fate determinants of drug induced cell-death mechanisms in Trypanosomatids

  2021cites this paper
• Miltefosine enhances infectivity of miltefosine-resistant Leishmania infantum by attenuating innate immune recognition

  2021cites this paper
• Improving the miltefosine efficacy against leishmaniasis by using different nanoassemblies made from surfactants or amphiphilic antimony (V) complex

  2021cites this paper
• Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis

  2020cites this paper
• Mode of action of a formulation containing hydrazones and saponins against leishmania spp. Role in mitochondria, proteases and reinfection process

  2020cites this paper
• In vitro inhibitory effect of Ambrosia maritima (Asteraceae) extract on the survival of Leishmania donovani

  2020cites this paper
• The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history

  2020cites this paper
• Antileishmanial Drugs Modulate IL-12 Expression and Inflammasome Activation in Primary Human Cells

  2020cites this paper
• De Novo Synthesis of Phosphatidylcholine Is Essential for the Promastigote But Not Amastigote Stage in Leishmania major

  2020cites this paper
• Association of Miltefosine with Granulocyte and Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Cutaneous Leishmaniasis in the Amazon Region: a randomized and controlled trial.

  2020cites this paper
• Interaction of Miltefosine with Microcavity Supported Lipid Membrane: Biophysical Insights from Electrochemical Impedance Spectroscopy

  2020cites this paper
• Comprehensive investigations on anti-leishmanial potentials of Euphorbia wallichii root extract and its effects on membrane permeability and apoptosis.

  2019cites this paper
• Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.

  2019cites this paper
• An evaluation of the antiparasitic activities of a novel natural product and open-access Pathogen Box libraries

  2019cites this paper
• Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani

  2019cites this paper
• Mitochondrial proteome profiling of Leishmania tropica.

  2019cites this paper
• A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis.

  2019cites this paper
• β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.

  2019cites this paper
• Imidazo[2,1-a]isoindole scaffold as an uncharted structure active on Leishmania donovani.

  2019cites this paper
• Current and promising novel drug candidates against visceral leishmaniasis

  2019cites this paper
• Exploring Endoperoxides as Leishmanicidal Compounds

  2019cites this paper
• Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold.

  2019cites this paper
• Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB/c mouse model.

  2019cites this paper
• Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake

  2019cites this paper
• Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development

  2019cites this paper
• The Biological Impact of Oxidative Metabolism in Trypanosomatid Parasites: What Is the Perfect Balance Between Reactive Species Production and Antioxidant Defenses?

  2019cites this paper
• Discovery and pharmacological studies of 4-hydroxyphenyl-derived phosphonium salts active in a mouse model of visceral leishmaniasis.

  2019cites this paper
• Oxidative Stress in Microbial Diseases

  2019cites this paper
• Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages

  2018cites this paper
• Emerging therapeutic targets for treatment of leishmaniasis

  2018cites this paper
• In vitro leishmanicidal effects of the anti-fungal drug natamycin are mediated through disruption of calcium homeostasis and mitochondrial dysfunction

  2018cites this paper
• Human Kinetoplastid Protozoan Infections: Where Are We Going Next?

  2018cites this paper
• Leishmania parasitophorous vacuole membranes display phosphoinositides that create conditions for continuous Akt activation and a target for miltefosine in Leishmania infections

  2018cites this paper
• The leishmanicidal activity of artemisinin is mediated by cleavage of the endoperoxide bridge and mitochondrial dysfunction

  2018cites this paper
• In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.

  2018cites this paper
• Drug Resistance Assays for Parasitic Diseases

  2017cites this paper
• MODE OF ACTION OF THE MAIN ANTI-PARASITIC DRUGS

  2017cites this paper
• Chapter 19 Alkylphospholipids and Leishmaniasis

  2017cites this paper
• Functional Involvement of Leishmania donovani Tryparedoxin Peroxidases during Infection and Drug Treatment

  2017cites this paper
• Phytochemicals With Antileishmanial Activity: Prospective Drug Targets

  2017cites this paper
• Alkylphospholipids: An update on molecular mechanisms and clinical relevance.

  2017influential citation
• Drug resistance and treatment failure in leishmaniasis: A 21st century challenge

  2017influential citation
• Chemotherapy of leishmaniasis: present challenges

  2017cites this paper
• Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca2+ Channel

  2017influential citation
• Screening a Natural Product-Based Library against Kinetoplastid Parasites

  2017cites this paper
• Drug resistance and treatment failure in leishmaniasis : A 21 st century challenge

  2017cites this paper
• Symmetrical Pyridinium-Phanes and –Diazacyclophanes — Promising Heterocyclic Scaffolds for the Development of Anti-Leishmanial Agents

  2016cites this paper
• Naloxonazine, an Amastigote-Specific Compound, Affects Leishmania Parasites through Modulation of Host-Encoded Functions

  2016cites this paper
• Current status on prevention and treatment of canine leishmaniasis.

  2016cites this paper
• Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.

  2016cites this paper
• Miltefosine Susceptibility and Resistance in Leishmania: From the Laboratory to the Field

  2016cites this paper
• The Importance of Targeting Lipid Metabolism in Parasites for Drug Discovery

  2016cites this paper
• Biologically active compounds from natural and marine natural organisms with antituberculosis, antimalarial, leishmaniasis, trypanosomiasis, anthelmintic, antibacterial, antifungal, antiprotozoal, and antiviral activities

  2016cites this paper
• Caractérisation des mécanismes de réarrangements géniques chez le parasite Leishmania résistant aux drogues

  2016cites this paper
• Estudo das interações da miltefosina com membranas de L. (Leishmania) amazonensis e macrófagos peritoneais

  2016cites this paper
• Experimental Resistance to Drug Combinations in Leishmania donovani: Metabolic and Phenotypic Adaptations

  2015cites this paper
• Dissecting Leishmania infantum Energy Metabolism - A Systems Perspective

  2015cites this paper
• Potential Relevance of Melatonin Against Some Infectious Agents: A Review and Assessment of Recent Research.

  2015cites this paper
• Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major

  2015cites this paper
• Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes.

  2015cites this paper
• Epidemiological studies on zoonotic leishmaniasis and new trials for studying the effect of melatonin on the parasite

  2015cites this paper
• Amino bis-pyridinium derivatives as novel antileishmanial agents 1 2

  2014cites this paper
• 4-Amino Bis-Pyridinium Derivatives as Novel Antileishmanial Agents

  2014cites this paper
• Mechanisms of Action of Substituted β-Amino Alkanols on Leishmania donovani

  2014cites this paper
• Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania

  2014cites this paper
• Activity of melatonin against Leishmania infantum promastigotes by mitochondrial dependent pathway.

  2014cites this paper
• Protein Binding Site Similarities as Driver for Drug Repositioning

  2014cites this paper
• Drug Resistance in Leishmania

  2014cites this paper